Product NDC: | 59762-3728 |
Proprietary Name: | clindamycin phosphate |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-3728 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050537 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19800620 |
Package NDC: | 59762-3728-1 |
Package Description: | 30 mL in 1 BOTTLE (59762-3728-1) |
NDC Code | 59762-3728-1 |
Proprietary Name | clindamycin phosphate |
Package Description | 30 mL in 1 BOTTLE (59762-3728-1) |
Product NDC | 59762-3728 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 19800620 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |